Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  dexrazoxane hydrochloride
Find trials that include:  Any drugs shown
Results 1-6 of 6 for your search:
Start Over
Imatinib Mesylate and Combination Chemotherapy in Treating Patients with Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Status: Active
Phase: Phase III
Type: Treatment
Age: 2 to 21
Trial IDs: AALL1631, NCI-2016-01588, NCT03007147
Risk Classification Schemes in Identifying Better Treatment Options for Children and Adolescents with Acute Lymphoblastic Leukemia
Status: Active
Phase: Phase III
Type: Treatment
Age: 1 to 21
Trial IDs: 16-001, NCI-2017-00431, NCT03020030
Iobenguane I-131 or Crizotinib and Standard Therapy in Treating Younger Patients with Newly-Diagnosed High-Risk Neuroblastoma or Ganglioneuroblastoma
Status: Not yet active
Phase: Phase III
Type: Treatment
Age: 365 days to 30 years
Trial IDs: ANBL1531, NCI-2016-01734, NCT03126916
Doxorubicin Hydrochloride, Dexrazoxane Hydrochloride, and Olaratumab in Treating Patients with Advanced or Metastatic Soft Tissue Sarcoma That Cannot Be Removed by Surgery
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 201510049, NCI-2015-01777, NCT02584309
Azacitidine or Decitabine in Epigenetic Priming in Patients with Newly Diagnosed Acute Myeloid Leukemia
Status: Active
Phase: Phase II
Type: Treatment
Age: 28 days to 22 years
Trial IDs: AML16, NCI-2017-00928, NCT03164057
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated with Cardiomyopathy and Heart Failure after Cancer Treatment
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology
Age: Not specified
Trial IDs: ALTE11C2, NCI-2012-03196, COG-ALTE11C2, S0004187, NCT01790152
Start Over